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Background: The prevalence of schizophrenia and depression in the United States is far higher among Medicaid
recipients than in the general population. Individuals suffering from mental illness, including schizophrenia and
depression, also have higher rates of emergency department utilization, which is costly and may not generate the
positive health outcomes desired. Disease management programs strive to help individuals suffering from chronic
illnesses better manage their condition(s) and seek health care in the appropriate settings. The objective of this
manuscript is to estimate a dose–response impact on hospital inpatient and emergency room utilizations for any
reason by Medicaid recipients with depression or schizophrenia who received disease management contacts.
Methods: Multivariate regression analysis of panel data taken from administrative claims was conducted to test the
hypothesis that increased contacts lower the likelihood of all-cause inpatient admissions and emergency room visits.
Subjects included 6,274 members of Illinois’ non-institutionalized Medicaid-only aged, blind or disabled population
diagnosed with depression or schizophrenia. The statistical measure is the odds ratio. The odds ratio association is
between the monthly utilization indicators and the number of contacts (doses) a member had for each particular
disease management intervention.
Results: Higher numbers of intervention contacts for Medicaid recipients diagnosed with depression or
schizophrenia were associated with statistically significant reductions in all-cause inpatient admissions and
emergency room utilizations.
Conclusions: There is a high correlation between depression and schizophrenia disease management contacts and
lowered all-cause hospital inpatient and emergency room utilizations.Background
The presence of mental illness is associated with substan-
tially higher per capita costs and all-cause hospitalization
rates compared to the general population [1]. Mental dis-
orders are among the five most costly health conditions to
treat and manage. In 2005, national expenditures for the
treatment of mental health and substance abuse disorders
were tallied at $135 billion, [2] and costs are expected to
grow to $239 billion by 2014 [3]. Of the 95 million visits
to U.S. emergency rooms in 2007, nearly 12 million visits,* Correspondence: Greg.Berg@McKesson.com
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reproduction in any medium, provided the oror one in eight, involved people with a mental disorder,
substance abuse problem, or both. Reflecting the fact that
Medicaid is the single largest payer for mental health
services in the U.S., [4] Medicaid was billed about 20 per-
cent of the time for these visits. Nearly 41 percent of
mental disorder and/or substance abuse-related emer-
gency department (ED) visits in 2007 resulted in a hos-
pital admission [5].
Between 1996 and 2006, the number of people with
health care expenditures associated with mental disorders
nearly doubled from 19.3 million to 36.2 million [6]. While
the prevalence of schizophrenia in the U.S. population is
only 1%, [7,8] the prevalence is over eight times higher in
U.S. Medicaid populations at 8.5% [1]. In Illinois, thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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about 10.2%; [9] however, the prevalence of depression in
the Illinois Medicaid population is more than 39% [1].
Given the high prevalence rates of schizophrenia and
depression among Medicaid populations, and the ex-
pense in managing these conditions, there is a strong
need to help affected individuals better manage their
mental health conditions.Chronic care model
The chronic care model (CCM) is a framework to guide
organizational and quality changes in the health care deliv-
ery system to improve the quality of care to people with
chronic conditions [10]. The CCM’s focus on the individ-
ual’s self-management of chronic conditions was the con-
ceptual prototype for Illinois’ Disease Management (DM)
program, called Your Healthcare Plus (YHP)™. This pro-
gram was offered through the Illinois Department of
Healthcare and Family Services and delivered by McKesson
Corporation. The CCM paradigm for health care delivery
and DM management centers around the partnership be-
tween members, staff, and providers, all of whom collabor-
ate for successful disease and self-management education
and support [11].Disease management
Disease Management emerged as an application of the
chronic care model in the mid-1990s, and is used as a
strategy to help mitigate costs for health care, particu-
larly the most costly services of inpatient hospital admis-
sions and ED visits [12,13]. While a consensus definition
of “disease management” remains ambiguous, [12,14] DM
programs do share as their primary objectives the improve-
ment of the quality, consistency and comprehensiveness of
cost-effective care for people with chronic illnesses. The
shared focus driving all DM programs is improving the
health plan member’s ability to self-manage their health
condition(s). Thus, DM programs endeavor to shore up
member health to avoid costly, unnecessary inpatient
hospital admissions, frequent hospital re-admissions, and
inappropriate ED utilization. DM program strategies in-
clude practices that focus on creating positive sustainable
changes in the member's behavior using both educational
and motivational strategies to encourage and support goal
achievement [15-17].
There is great variation between state Medicaid pro-
grams, and DM at the state level is no exception. State
Medicaid programs differ in how they select potential
DM participants and vary in organizational and struc-
tural design. For instance, the diagnosis codes used to
identify conditions, the list of conditions to be managed,
and the benefit design such as fee-for-service or man-
aged care can vary greatly.For the Illinois Your Healthcare Plus program, individ-
ual health care goals were established in collaboration
with participants and their medical homes or primary
care physicians. The basic Medicaid benefit package and
service access did not change for those participating in
the program; medical services were still paid for through
Medicaid. Where services such as Assertive Community
Treatment were available or where there may have been
a practice-based medical home Registered Nurse (RN)
care coordinator available, the role of the DM RN was
not to take the place of these services, but to support
the member’s continued use of these services. It should
be noted, however, that due to budgetary constraints for
much of the state, often these services were unavailable.
Therefore, the focus of the DM RN was to facilitate and
support member engagement in any locally available and
relevant behavioral and/or medical services.
As many as 38 states have engaged in DM programs
for a portion of their Medicaid population, [18] and
many self-insured employers have offered DM programs
to their employees. Previous dose response literature in
the DM domain includes a recent study that found that
inpatient admissions dropped by the greatest extent after
four or more contacts [19]. This study, however, was lim-
ited to people with chronic physical health conditions and
not behavioral health conditions, such as schizophrenia
and depression.
Key contribution
The key contribution of this study is to estimate a dose
response effect for a DM program designed to improve
both care to individuals and cost effective appropriate
utilization among Illinois’ Medicaid-only recipients with
behavioral health conditions. The literature review found
no dose response studies related to a behavioral health




Ethics approval/IRB approval was not necessary as the
study was performed as part of a DM program using ad-
ministrative claims data accessible to all authors.
Subjects
On July 1, 2006, the state of Illinois implemented the Your
Healthcare Plus (YHP) DM program, which included the
adult aged, blind, and disabled (ABD) Medicaid-only popu-
lation living in the community and who were non-
institutionalized. In fiscal year 2007, the entire Illinois ABD
population enrolled in a DM program represented 4.41%
of the state’s total Medicaid members, but accounted for
over 18% of the state’s Medicaid expenditures, as calculated
by Illinois administrative claims analysis.
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incurred between July 2005 and June 2009 for the ABD
Medicaid population living in non-institutional settings.
Additionally, subject inclusion criteria required members
to have at least two different claims with a diagnosis of
depression (DSM-IV criteria and codes for major depres-
sive disorder, dysthymia, and depression not otherwise
classified) or schizophrenia. Inclusion criteria for this
study also require that subjects were continuously en-
rolled in Medicaid between July 2005 and June 2009.
The total number of subjects with at least one of these
conditions or diagnoses and eligible for the intervention
was 6,274. Of that number, 1,738 individuals (27.7%)
self-selected in to the DM program, were contacted by a
nurse, and received interventions at some point between
July 2006 and June 2009.
Intervention
Registered nurses began contacting identified subjects di-
agnosed with one or both behavioral health conditions
(depression or schizophrenia) for DM program enrollment
in July 2006. These nurses had at least 5 years of acute
care experience and completed 6 weeks of training prior
to launch of the DM program. This training included
condition-specific information on national clinical guide-
lines for outpatient management standards, characteris-
tics, and behaviors. Training also included practice in the
use of motivational interviewing techniques and concepts
[20,21] that help successfully engage members and sup-
port them in making better health choices. Furthermore,
the training included numerous self-study modules, in-
cluding communication techniques, cultural sensitivity
and awareness, required competencies, and monthly
physician-led clinical patient review sessions.
Nurse-led interventions focused on enabling the indi-
vidual to change their behaviors for improved health and
well-being. Nurses provided support regarding lifestyle
choices, appropriate use of a medical and/or behavioral
therapy home, medication adherence, and participation
in other behaviors and habits such as smoking or dietary
patterns that may negatively impact well-being.
Members were not randomized into an intervention or
control group. For those members who chose to enroll
and were able to be contacted, the YHP program custom-
ized a self-management intervention plan that included
risk stratification, planned education and counseling ses-
sions where nurses worked with participants to help them
understand specific disease management skills and be-
haviors, 24-hour access to nurse counseling, and other
sources of condition or symptom advice including tele-
phonic support, printed action plans, and workbooks. In
addition, participants received individualized assess-
ment letters and reminders for medication compliance
and vaccination. Physicians received alerts about criticalsigns and symptoms of decompensation and notification
of gaps between participant-reported practices and guide-
line recommendations.
Whether they participate in a DM program or not,
health plan members very commonly present with mul-
tiple co-occurring physical and behavioral health condi-
tions. The DM program interventions were designed to
address both types of conditions by assessing each indi-
vidual to determine what was most pressing ‘at the mo-
ment,’ recognizing the interplay between the conditions
and the mind-body relationship.
Participating members received multiple contacts
throughout the course of the intervention period. A
contact was any interaction related to the participant’s
condition. Examples of contacts up to and including the
month of measurement are described below and include
(1) health assessments (initial, biannual, and annual);
(2) monitoring and educational contacts; and (3) inbound
symptomatic contacts by participants. Doses were de-
fined as the number of cumulative contacts of any kind
that a participant had up to, and including, the month
of analysis.
Member assessments
The nursing assessments (initial, biannual, and annual)
included gathering participating members’ self-reported
information on areas such as medication use, adherence
to their physician’s recommendations, barriers to care,
knowledge of their condition(s) and symptoms, current
self-management practices, use of a medical home, and
recent ED or inpatient utilization. This self-reported infor-
mation was included in each member’s record. Assess-
ments were always conducted by an RN. While most
assessments were done telephonically, some were con-
ducted face-to-face at a mutually agreed upon location
with the participating member. An assessment could have
been completed in a single session or in more than one
session, depending on the willingness of the member. In
the case of an incomplete assessment, the nurse would
schedule a follow-up session and gather the remaining in-
formation. Upon completion of the assessment, an indi-
vidualized care plan was created.
Assessments occurred initially upon enrollment of a
member into the DM program and thereafter at six month
intervals to update member status data and to update or
revise the care plan and member goals. Providers received
a summary letter of member self-reported data along with
information on how to contact the DM nurse. Nursing
staff also made regular visits to provider practices to col-
laborate on member management.
Member monitoring/education contacts
The monitoring and education contacts were scheduled
sessions that occurred in the interim period between
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cluded addressing the participating member’s care plan
challenges and any other pressing member concerns.
Nursing staff used motivational interviewing techniques
to facilitate needed behavior changes for the participant
to be able to effectively self-manage their condition(s).
Condition-specific education was provided and varied
depending on the member’s specific needs. Educational
content included information to enhance member under-
standing of their health condition(s), instructions on medi-
cation use, guidance on lifestyle choices, and direction on
how to recognize symptoms of decompensation and the
appropriate actions to take. To support communications
between the member and their providers, mock scenarios
were play acted between the nurse and members requiring
this level of assistance.
While the primary staff delivering interventions in the
YHP program were Registered Nurses, other program
staff included social workers, community health workers,
and behavioral health specialists.
Unscheduled symptomatic member contacts
Inbound symptomatic member contacts were unsched-
uled telephonic communications that occurred in addition
to the scheduled monitoring and education contacts de-
scribed above. These inbound contacts occurred when a
participating member reported health symptoms, flagging
the nurse to follow up the next day to ensure that the ap-
propriate steps had been taken. This contact type was also
used to address other member-reported issues that that
were appropriate for follow-up prior to the next scheduled
contact. Examples include follow-up with the member
after a visit to a provider, and DM staff counseling when a
participating member wanted to discuss current symp-
toms or other urgent needs.
Research design
Panel/longitudinal data was used for this analysis. The
unit of measurement was the individual Medicaid member
month with each participating member measured for each
calendar month between July 2005 and June 2009. All
members in the analysis were continuously eligible for
DM services between July 2005 and June 2009. Because
the intervention began in July 2006, the 12 months of data
between July 2005 and June 2006 did not have any DM
program contacts for any members.
Given the panel data structure of one observation for
each member for each month of their Medicaid eligibility,
a member could have switched from a non-intervention
status to an intervention status for subsequent months.
That is, since each member was continuously eligible for
the entire 48 month period, if the member began receiving
intervention contacts in month 37, then only months 37–
48 were logged as months with an indicated contact. Oncea member started receiving intervention contacts, every
subsequent month was indicated as a month of contact,
since the contacts in each month are the cumulative num-
ber of contacts a member has had up to that point.
Multivariate regression analysis of panel data was used
to evaluate the intervention and test the hypothesis that
increased DM contacts lowered the odds of an inpatient
admission or emergency room visit. The dependent vari-
able was the dichotomous indicator as to whether or not
the member had an inpatient admission in a given month,
or had an ED visit for those separate regressions. For each
monthly observation, an indicator of whether or not an in-
patient admission or ED visit occurred during that month
was calculated. The dichotomous formulation of this vari-
able allows for a logistic regression to be estimated and
odds ratios to be calculated.
The independent or explanatory variables included (i) an
identification indicator showing whether or not a member
had been identified for a particular DM intervention or
plan of care for their depression or schizophrenia, (ii) the
cumulative number of contacts (doses) for each particular
intervention a member has had, including doses squared
and cubed, (iii) a high risk indicator, defined as members
identified as having cancer, end stage renal disease, HIV,
hemophilia, traumatic brain injury or a previous organ
transplant, (iv) age/gender grouping, (v) the predictive
model risk score prior to identification of each member
for a DM program calculated by the predictive modeling
company MEDai, [22] and (vi) a time variable which
was incremented by one for each month to account for
potential trends.
Multivariate regression analysis allowed for simultan-
eous estimation of several explanatory variables influ-
encing a participating member either at the same or
different times. That is, if a member had both depres-
sion and schizophrenia, the number of contacts related
to each condition was used as an explanatory variable.
In cases such as this, there was one explanatory vari-
able for the cumulative number of depression contacts
up to that month, as well as one explanatory variable
for the cumulative number of schizophrenia contacts
up to that month.
To calculate the dose response effect, a cubic repre-
sentation was chosen to allow for a flexible functional
representation. This flexibility allowed for a quadratic
and linear dose response relationship as a special case.
Contact or dose variables were calculated for each con-
dition. For instance, the number of depression contacts,
the number of depression contacts squared, and the num-
ber of depression contacts cubed was calculated. The coeffi-
cients of each of these three variables were then estimated
in the regression analysis and used to estimate the odds
ratio for each level of contact by exponentiation of the coef-
ficient estimates.












High Risk Members (%) 5.6 6.2 5.4
Risk Score (Mean) 33.1 32.9 33.1
Female (%) 60.2 60.2 60.2
Female age less than
29 (%)
7.4 6.0 7.9
Female age 30–39 (%) 11.5 10.0 12.1
Female age 40–49 (%) 21.0 21.5 20.9
Female age 50+ (%) 20.3 22.7 19.4
Male age less than 29 (%) 9.0 8.2 9.2
Male age 30–39 (%) 8.5 8.5 8.5
Male age 40–49 (%) 14.0 14.1 14.0
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Descriptive statistics
Table 1 shows that of the 6,274 members who were di-
agnosed with either depression or schizophrenia, 1,738
































Figure 1 Dose response impact for depression inpatient admissions.
95% confidence interval. Those number of contacts with a confidence inteat least one month at some point over the 3 year inter-
vention time period. All participating members were
continuously enrolled for the entire 48 months, which
included the 12 months prior to the start of the inter-
vention. High risk members accounted for 5.6% of the
population, while 3.9% of the members were identified for
both the depression and schizophrenia programs. The an-
nualized inpatient admission rate per 1,000 members was
671.1, and the annualized ED utilization rate was 1,793.1,
indicating that these members were heavy users of the
health care system. In addition, face-to-face contacts
accounted for less than 1% for all contact types for both
conditions, except for schizophrenia symptomatic con-
tacts which accounted for 3.6% of contacts.
Multivariate regression results
The dose response impact is considered statistically sig-
nificant (rejecting the null hypothesis that the dose vari-
able odds ratio is 1.0) if Pearson’s chi-square test p-value
is less than the critical value. Figures 1 and 2 show the
all-cause inpatient admission and ED visit results by
dose (nurse contact) level for members with depression.
Figures 3 and 4 show similar all-cause inpatient admis-
sion and ED visit results for members with schizophre-
nia. The points in each figure represent the odds ratio,
whereas the lines indicate the 95% confidence interval. If
the confidence interval contains the number 1, then that
particular odds ratio is not statistically significant at the
5% level. Table 2 shows the same odds ratios and levels of
statistical significance for each level of contact for critical
values of 1%, 5%, and 10%.
For participating members with depression, all-cause in-
patient admissions showed statistically significant impact
from one to nine contacts with odds ratios between 0.8
and 0.62. Depression DM program impact on emergency7 8 9 10 11 12 13
 of Contacts
Diamonds represent the odds ratio estimate. The lines represent the
































Figure 2 Dose response impact for depression emergency department visits. Diamonds represent the odds ratio estimate. The lines
represent the 95% confidence interval. Those number of contacts with a confidence interval that does not cross the green line are
statistically significant.
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inpatient admissions. Results were statistically significant
from two to four contacts, with odds ratios ranging from
0.89 to 0.86.
For schizophrenia, all-cause inpatient admissions showed
statistically significant impact from four to eleven contacts
with odds ratios between 0.75 and 0.34. Similar to the
above finding for the depression DM program, schizophre-
nia DM program impact on emergency room utilization
































Figure 3 Dose response impact for schizophrenia inpatient admission
95% confidence interval. Those number of contacts with a confidence inteadmissions. Results were statistically significant from six to
twelve contacts, with odds ratios ranging from 0.78 to 0.68.
For both depression and schizophrenia, the increased
number of contacts showed greater impact on reduc-
tions in inpatient admissions than it did on the number
of ED visits. This indicates that the intervention had less
influence in reducing ED visits as compared to inpatient
admissions. For participating members with schizophre-
nia, more contacts were required to show a statistically
significant reduction in ED and inpatient admissions as7 8 9 10 11 12 13
 of Contacts
s. Diamonds represent the odds ratio estimate. The lines represent the

































Figure 4 Dose response impact for schizophrenia emergency department visits. Diamonds represent the odds ratio estimate. The lines
represent the 95% confidence interval. Those number of contacts with a confidence interval that does not cross the green line are
statistically significant.
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where impacts were seen with fewer contacts.
Discussion
Figures 1, 2, 3 and 4 reveal some insights in the manage-
ment of Medicaid members with depression or schizophre-
nia. First, the reductions in all-cause inpatient admissions
happened sooner for participating members with depres-
sion than for participating members with schizophrenia.
As such, measurable impacts can be seen faster for those
members with depression. Second, for both disease states,Table 2 Odds ratios by condition by number of doses
Inpatient admissions ED visits
Doses Depression Schizophrenia Depression Schizophrenia
1 0.80*** 0.97 0.93* 1.09**
2 0.68*** 0.91 0.89** 1.11
3 0.61*** 0.84 0.86** 1.07
4 0.57*** 0.75** 0.86** 0.99
5 0.55*** 0.67*** 0.86* 0.89
6 0.55*** 0.59*** 0.87 0.78**
7 0.57*** 0.52*** 0.88 0.7***
8 0.59*** 0.46*** 0.88 0.63***
9 0.62** 0.41*** 0.88 0.59***
10 0.65* 0.37*** 0.86 0.58***
11 0.68 0.34** 0.83 0.6***
12 0.70 0.31* 0.77 0.68**
13 0.71 0.30 0.70 0.83
*P-value < = 0.10.
**P-value < = 0.05.
***P-value < = 0.01.higher numbers of contacts were not statistically significant
in reducing inpatient admissions or ED utilization. It is
doubtful that this is due to a lack of program impact, but
rather due to fewer people having very high numbers of
contacts. All participants had at least one contact by a DM
nurse, but only 2.5% of depression and 0.7% of schizophre-
nia members had 13 or more contacts. Third, similar to in-
patient admissions, impacts in the number of ED visits
required a higher number of contacts to show statistically
significant reductions. This data reveals that participating
members with schizophrenia took longer to show pro-
grammatic impacts both in terms of the number of in-
patient admissions and in terms of ED visits. This is due to
the larger variance in ED utilization measured for partici-
pating members with depression. However, although mem-
bers with depression had statistically significant reductions
in the number of ED visits sooner than those members
with schizophrenia, the effects diminished faster in terms
of statistical significance, due again to the larger variance
in the number of ED visits.
One limitation of this study may be its generalizability.
This study was specific to a state Medicaid population,
and translating these findings to either another Medicaid
population or to a commercially insured population may
not be valid. This, however, suggests an area for future
research. Another limitation is the quasi-experimental
study design. Selection bias may exist because members
may choose whether to participate in the program for
reasons that may not be controlled for with the observable
variables. For example, certain members may be more
motivated for self-care or have different complexities re-
lated to their disease(s). Predictive risk adjustment may be
a possible control. As well, even though members agree to
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contacts are determined through risk assessment. Apart
from an experimental design, the magnitude of this poten-
tial bias cannot be determined. A further limitation is
restricting the sample to continuously enrolled members.
Medicaid members do churn in and out of eligibility; how-
ever, continuously enrolled members were chosen to en-
sure that each person was equally represented and had
complete data. Finally, dose timing was not examined here
but might provide further insights into the effect of the
intervention. Future analyses could examine the differen-
tial effects of 12 monthly doses versus 12 doses received
over the course of 2 years.
Conclusions
Program staff cited that the most difficult challenges in
delivering effective DM programs stem from the partici-
pating populations’ burden of illness, dysfunctional pat-
terns of health behaviors, and years of barriers to access to
care that have contributed to unfortunate decision making
in their own health care and lifestyle choices. Due to both
the varied nature of human behavior and the complexity
of chronic health problems, achieving a positive impact on
health outcomes and behaviors must rely on a multi-
pronged approach that focuses on supporting and motiv-
ating the individual member. For members with chronic
mental illnesses, a caring, individualized approach pro-
vides the attention that they may not otherwise perceive
as being provided.
This study has evaluated a multipronged approach focus-
ing on supporting and motivating the individual member.
A thorough analysis of the program data found statistically
significant reductions of all-cause inpatient hospitalizations
and ED visits for Medicaid members diagnosed with de-
pression or schizophrenia. These reductions were based on
the number of contacts and were not the result of denying
inpatient utilization or restricting treatment.
This analytical work has been valuable for Illinois
Medicaid and the Your Healthcare Plus program by pro-
viding data-driven information that may be used in mak-
ing program modifications and staffing adjustments.
Program changes suggested by these results include al-
tering the schedule of contacts and ensuring both regu-
lar and ad hoc contacts to meet participating member
needs. It is important that resources be allocated for in-
terventions where the best opportunities for improve-
ments in DM program outcomes may exist. As this is
the first dose response study related to a non-drug DM
intervention for behavioral health in the literature, add-
itional future studies are needed in this area to deter-
mine further methods of improving health outcomes.
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